Second, in breast cancer, detection of FYN levels in clinical samples using immunohistochemical techniques (IHC) revealed that FYN expression levels are significantly higher in breast cancer than in adjacent normal tissues and are an important factor in the poor prognosis of breast cancer [183]. This evidence concerns the gene FYN and breast cancer.